Update shared on 20 Nov 2025
Fair value Decreased 8.31%Georg Fischer's fair value estimate has been reduced from CHF 79.40 to CHF 72.80. Analysts point to increased end market risks and more cautious outlooks on revenue growth and price targets.
Analyst Commentary
Recent analyst coverage reflects a wide range of perspectives on Georg Fischer's outlook, with some taking a more cautious stance while others maintain optimism about the company’s prospects.
Bullish Takeaways
- Bullish analysts see long-term fundamentals as supportive of continued growth. They reiterate positive ratings and relatively higher price targets despite recent market volatility.
- Some view current valuation levels as an attractive entry point and emphasize the company’s resilient business model and opportunities in its core segments.
- Expectations for operational improvements and strategic initiatives support optimism around future earnings contributions and margin expansion.
- Bullish outlooks highlight Georg Fischer’s position to benefit from recovery trends as macroeconomic conditions stabilize.
Bearish Takeaways
- Bearish analysts point to heightened end market risks, which may lead to weaker revenue growth and profit headwinds in the near term.
- Lowered price targets reflect growing concerns over potentially optimistic consensus estimates, with some expecting shortfalls against prior forecasts.
- There are cautionary signals about execution risks, particularly if demand conditions continue to soften across key segments.
- Some view the stock as fully valued at current levels, with limited upside in the absence of a more robust rebound in operating performance.
What's in the News
- Harrington Process Solutions announced a strategic expansion of its partnership with Georg Fischer, granting full-line access to Georg Fischer’s portfolio for corrosive waste and high purity applications in the U.S. (Key Developments)
- The expanded collaboration enhances Harrington’s capabilities to serve mission-critical industries, including Data Centers, Life Sciences and Biopharmaceuticals, and Food and Beverage. (Key Developments)
- Customers benefit from advanced infrastructure solutions, technical expertise, extensive distribution via more than 90 U.S. locations, and personalized, streamlined procurement support. (Key Developments)
Valuation Changes
- Fair Value Estimate has fallen from CHF 79.40 to CHF 72.80. This reflects a notable decrease in estimated equity value.
- Discount Rate has risen slightly from 6.21% to 6.31%. This indicates a marginally higher risk premium applied in updated forecasts.
- Revenue Growth projection has declined significantly from -0.12% to -3.56%. This suggests a more negative outlook for top-line performance.
- Net Profit Margin is expected to increase from 7.88% to 8.22%. This points to anticipated improvements in profitability despite lower revenues.
- Future P/E Ratio has edged down from 26.57x to 26.00x. This reflects more conservative expectations for future earnings multiples.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.